Mast cells in renal inflammation and fibrosis: Lessons learnt from animal studies

Molecular Immunology

Volumn 63, Issue 1, 2015, Pages 86-93

  Madjene, Lydia Celia ^a,b   Pons, Maguelonne ^a,b   Danelli, Luca ^a,b   Claver, Julien ^a,b   Ali, Liza ^a,b   Madera Salcedo, Iris K ^a,b   Kassas, Asma ^a,b   Pellefigues, Christophe ^a,b   Marquet, Florian ^a,b   Dadah, Albert ^a,b   Attout, Tarik ^a,b   El Ghoneimi, Alaa ^a,b,d   Gautier, Gregory ^a,b   Benhamou, Marc ^a,b   Charles, Nicolas ^a,b   Daugas, Eric ^a,b,c,e   Launay, Pierre ^a,b   Blank, Ulrich ^a,b  

^a CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c P R E S Paris Sorbonne Cité   (France)

^d HÔPITAL ROBERT DEBRÉ   (France)

^e BICHAT HOSPITAL   (France)

Author keywords

Fibrosis lupus nephritis; Mast cell chymase; Mast cells; Renal disease

Indexed keywords

ACUTE KIDNEY FAILURE; GLOMERULONEPHRITIS; HUMAN; KIDNEY CAPSULE; KIDNEY FIBROSIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MAST CELL; NEPHRITIS; NONHUMAN; REVIEW; ANIMAL; CHRONIC KIDNEY FAILURE; DISEASE MODEL; FIBROSIS; IMMUNOLOGY; KIDNEY; MOUSE; PATHOLOGY;

ANIMALIA;

ACUTE KIDNEY INJURY; ANIMALS; DISEASE MODELS, ANIMAL; FIBROSIS; GLOMERULONEPHRITIS; HUMANS; KIDNEY; LUPUS NEPHRITIS; MAST CELLS; MICE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84908457694     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.03.002     Document Type: Review

References (76)

1. Abdel-Hafez M., Shimada M., Lee P.Y., Johnson R.J., Garin E.H. Idiopathic nephrotic syndrome and atopy: is there a common link?. Am. J. Kidney Dis. 2009, 54:945-953.
2. Abraham S.N., St John A.L. Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol. 2010, 10:440-452.
3. Beghdadi W., Madjene L.C., Benhamou M., Charles N., Gautier G., Launay P., Blank U. Mast cells as cellular sensors in inflammation and immunity. Front. Immunol. 2011, 2:37.
4. Beghdadi W., Madjene L.C., Claver J., Pejler G., Beaudoin L., Lehuen A., Daugas E., Blank U. Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction. Kidney Int. 2013, 84:317-326.
5. Blank U., Essig M., Scandiuzzi L., Benhamou M., Kanamaru Y. Mast cells and inflammatory kidney disease. Immunol. Rev. 2007, 217:79-95.
6. Blank U., Rivera J. The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol. 2004, 25:266-273.
7. Charles N., Hardwick D., Daugas E., Illei G.G., Rivera J. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat. Med. 2010, 16:701-707.
8. Colvin R.B., Dvorak A.M., Dvorak H.F. Mast cells in the cortical tubular epithelium and interstitium in human renal disease. Hum. Pathol. 1974, 5:315-326.
9. Danilewicz M., Wagrowska-Danilewicz M. Quantitative analysis of interstitial mast cells in lupus and non-lupus membranous glomerulopathy. Pol. J. Pathol. 2001, 52:211-217.
10. Danilewicz M., Wagrowska-Danilewicz M. Quantitative analysis of the interstitial mast cells in idiopathic mesangiocapillary glomerulonephritis type I. Nefrologia 2001, 21:253-259.
11. Dhaun N., Webb D.J., Kluth D.C. Endothelin-1 and the kidney-beyond BP. Br. J. Pharmacol. 2012, 167:720-731.
12. DuBose T.D. American Society of Nephrology Presidential Address 2006: chronic kidney disease as a public health threat-new strategy for a growing problem. J. Am. Soc. Nephrol. 2007, 18:1038-1045.
13. Dudeck A., Dudeck J., Scholten J., Petzold A., Surianarayanan S., Kohler A., Peschke K., Vohringer D., Waskow C., Krieg T., Muller W., Waisman A., Hartmann K., Gunzer M., Roers A. Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity 2011, 34:973-984.
14. Eddy A.A. Mast cells find their way to the kidney. Kidney Int. 2001, 60:375-377.
15. Ehara T., Shigematsu H. Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis. Kidney Int. 1998, 54:1675-1683.
16. Ehara T., Shigematsu H. Mast cells in the kidney. Nephrology (Carlton) 2003, 8:130-138.
17. El-Koraie A.F., Baddour N.M., Adam A.G., El Kashef E.H., El Nahas A.M. Role of stem cell factor and mast cells in the progression of chronic glomerulonephritides. Kidney Int. 2001, 60:167-172.
18. El Kossi M.M., El Nahas A.M. Stem cell factor and crescentic glomerulonephritis. Am. J. Kidney Dis. 2003, 41:785-795.
19. Elkayam O., Tamir R., Pick A.I., Wysenbeek A. Serum IgE concentrations, disease activity, and atopic disorders in systemic lupus erythematosus. Allergy 1995, 50:94-96.
20. Eller K., Wolf D., Huber J.M., Metz M., Mayer G., McKenzie A.N., Maurer M., Rosenkranz A.R., Wolf A.M. IL-9 production by regulatory T cells recruits mast cells that are essential for regulatory T cell-induced immune suppression. J. Immunol. 2011, 186:83-91.
21. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M. Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 2005, 23:749-786.
22. Galli S.J., Tsai M., Piliponsky A.M. The development of allergic inflammation. Nature 2008, 454:445-454.
23. Hardwicke J., Soothill J.F., Squire J.R., Holti G. Nephrotic syndrome with pollen hypersensitivity. Lancet 1959, 1:500-502.
24. Hiromura K., Kurosawa M., Yano S., Naruse T. Tubulointerstitial mast cell infiltration in glomerulonephritis. Am. J. Kidney Dis. 1998, 32:593-599.
25. Hochegger K., Siebenhaar F., Vielhauer V., Heininger D., Mayadas T.N., Mayer G., Maurer M., Rosenkranz A.R. Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis. Eur. J. Immunol. 2005, 35:3074-3082.
26. Hochegger K., Wolf D., Rosenkranz A.R. CD4CD25 regulatory T cells: a new treatment option in glomerulonephritis. Kidney Int. 2005, 68:1898-1899.
27. Holdsworth S.R., Summers S.A. Role of mast cells in progressive renal diseases. J. Am. Soc. Nephrol. 2008, 19:2254-2261.
28. Hughson M., Farris A.B., Douglas-Denton R., Hoy W.E., Bertram J.F. Glomerular number and size in autopsy kidneys: the relationship to birth weight. Kidney Int. 2003, 63:2113-2122.
29. Jahan I., Hanif M., Ali M.A., Waliullah S.M., Mia A.H. Relationship between serum IgE and frequent relapse idiopathic nephrotic syndrome. Mymensingh Med. J. 2011, 20:484-489.
30. Jones C.L., Buch S., Post M., McCulloch L., Liu E., Eddy A.A. Pathogenesis of interstitial fibrosis in chronic purine aminonucleoside nephrosis. Kidney Int. 1991, 40:1020-1031.
31. Jones S.E., Kelly D.J., Cox A.J., Zhang Y., Gow R.M., Gilbert R.E. Mast cell infiltration and chemokine expression in progressive renal disease. Kidney Int. 2003, 64:906-913.
32. Kanamaru Y., Scandiuzzi L., Essig M., Brochetta C., Guerin-Marchand C., Tomino Y., Monteiro R.C., Peuchmaur M., Blank U. Mast cell-mediated remodeling and fibrinolytic activity protect against fatal glomerulonephritis. J. Immunol. 2006, 176:5607-5615.
33. Kim D.H., Moon S.O., Jung Y.J., Lee A.S., Kang K.P., Lee T.H., Lee S., Chai O.H., Song C.H., Jang K.Y., Sung M.J., Zhang X., Park S.K., Kim W. Mast cells decrease renal fibrosis in unilateral ureteral obstruction. Kidney Int. 2009, 75:1031-1038.
34. Kitoh T., Ishikawa H., Ishii T., Nakagawa S. Elevated SCF levels in the serum of patients with chronic renal failure. Br. J. Haematol. 1998, 102:1151-1156.
35. Klahr S., Morrissey J. Obstructive nephropathy and renal fibrosis. Am. J. Physiol. Renal Physiol. 2002, 283:F861-F875.
36. Lai K.W., Wei C.L., Tan L.K., Tan P.H., Chiang G.S., Lee C.G., Jordan S.C., Yap H.K. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J. Am. Soc. Nephrol. 2007, 18:1476-1485.
37. Laurent J., Lagrue G., Sobel A. Increased serum IgE levels in patients with lupus nephritis. Am. J. Nephrol. 1986, 6:413-414.
38. Laurent J., Rostoker G., Robeva R., Bruneau C., Lagrue G. Is adult idiopathic nephrotic syndrome food allergy? Value of oligoantigenic diets. Nephron 1987, 47:7-11.
39. Lavo B., Nilsson B., Loof L., Nilsson U.R., Ekdahl K.N. Fc receptor function and circulating immune complexes in gluten sensitive enteropathy-possible significance of serum IgA. Gut 1991, 32:876-880.
40. Levi-Schaffer F., Piliponsky A.M. Tryptase, a novel link between allergic inflammation and fibrosis. Trends Immunol. 2003, 24:158-161.
41. Lilla J.N., Chen C.C., Mukai K., BenBarak M.J., Franco C.B., Kalesnikoff J., Yu M., Tsai M., Piliponsky A.M., Galli S.J. Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice. Blood 2011, 118:6930-6938.
42. v mice to pristane-induced experimental lupus nephritis. Immunol. Lett. 2004, 91:93-97.
43. Mack M., Rosenkranz A.R. Basophils and mast cells in renal injury. Kidney Int. 2009, 76:1142-1147.
44. Marshall J.S. Mast-cell responses to pathogens. Nat. Rev. Immunol. 2004, 4:787-799.
45. Maurer M., Wedemeyer J., Metz M., Piliponsky A.M., Weller K., Chatterjea D., Clouthier D.E., Yanagisawa M.M., Tsai M., Galli S.J. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004, 432:512-516.
46. Miyazawa S., Hotta O., Doi N., Natori Y., Nishikawa K. Role of mast cells in the development of renal fibrosis: use of mast cell-deficient rats. Kidney Int. 2004, 65:2228-2237.
47. Odobasic D., Gan P.Y., Summers S.A., Semple T.J., Muljadi R.C., Iwakura Y., Kitching A.R., Holdsworth S.R. Interleukin-17A promotes early but attenuates established disease in crescentic glomerulonephritis in mice. Am. J. Pathol. 2011, 179:1188-1198.
48. Oka T., Kalesnikoff J., Starkl P., Tsai M., Galli S.J. Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice. Lab. Invest. 2012, 92:1472-1482.
49. Ooi B.S., Pesce A.J., First M.R., Pollak V.E., Bernstein I.L., Jao W. IgE levels in interstitial nephritis. Lancet 1974, 1:1254-1256.
50. Pardo J., Diaz L., Errasti P., Idoate M., de Alava E., Sola I., Lozano L., Panizo A. Mast cells in chronic rejection of human renal allografts. Virchows Arch. 2000, 437:167-172.
51. Park S.Y., Ueda S., Ohno H., Hamano Y., Tanaka M., Shiratori T., Yamazaki T., Arase H., Arase N., Karasawa A., Sato S., Ledermann B., Kondo Y., Okumura K., Ra C., Saito T. Resistance of Fc receptor-deficient mice to fatal glomerulonephritis. J. Clin. Invest. 1998, 102:1229-1238.
52. Pavone-Macaluso M. Tissue mast cells in renal diseases. Acta Pathol. Microbiol. Scand. 1960, 50:337-346.
53. Pejler G., Abrink M., Ringvall M., Wernersson S. Mast cell proteases. Adv. Immunol. 2007, 95:167-255.
54. Pelletier C., Guerin-Marchand C., Iannascoli B., Marchand F., David B., Weyer A., Blank U. Specific signaling pathways in the regulation of TNF-alpha mRNA synthesis and TNF-alpha secretion in RBL-2H3 mast cells stimulated through the high affinity IgE receptor. Inflamm. Res. 1998, 47:493-500.
55. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N. Engl. J. Med. 2008, 358:929-939.
56. Ravinal R.C., Costa R.S., Coimbra T.M., Dantas M., dos Reis M.A. Mast cells, TGF-beta1 and myofibroblasts expression in lupus nephritis outcome. Lupus 2005, 14:814-821.
57. Ries F., Klastersky J. Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am. J. Kidney Dis. 1986, 8:368-379.
58. Roberts I.S., Brenchley P.E. Mast cells: the forgotten cells of renal fibrosis. J. Clin. Pathol. 2000, 53:858-862.
59. Rodewald H.R., Feyerabend T.B. Widespread immunological functions of mast cells: fact or fiction?. Immunity 2012, 37:13-24.
60. Rüger B.M., Hasan Q., Greenhill N.S., Davis P.F., Dunbar P.R., Neale T.J. Mast cells and type VIII collagen in human diabetic nephropathy. Diabetologia 1996, 39:1215-1222.
61. Sakamoto-Ihara T., Suzuki Y., Kurusu A., Yamashita M., Horikoshi S., Tomino Y. Possible involvement of mast cells in renal fibrosis in patients with IgA nephropathy. Inflamm. Res. 2007, 56:421-427.
62. Sandberg D.H., Bernstein C.W., McIntosh R.M., Carr R., Strauss J. Severe steroid-responsive nephrosis associated with hypersensitivity. Lancet 1977, 1:388-391.
63. Scandiuzzi L., Beghdadi W., Daugas E., Abrink M., Tiwari N., Brochetta C., Claver J., Arouche N., Zang X., Pretolani M., Monteiro R.C., Pejler G., Blank U. Mouse mast cell protease-4 deteriorates renal function by contributing to inflammation and fibrosis in immune complex-mediated glomerulonephritis. J. Immunol. 2010, 185:624-633.
64. Schlondorff D.O. Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int. 2008, 74:860-866.
65. Summers S.A., Chan J., Gan P.Y., Dewage L., Nozaki Y., Steinmetz O.M., Nikolic-Paterson D.J., Kitching A.R., Holdsworth S.R. Mast cells mediate acute kidney injury through the production of TNF. J. Am. Soc. Nephrol. 2011, 22:2226-2236.
66. Summers S.A., Gan P.Y., Dewage L., Ma F.T., Ooi J.D., O'Sullivan K.M., Nikolic-Paterson D.J., Kitching A.R., Holdsworth S.R. Mast cell activation and degranulation promotes renal fibrosis in experimental unilateral ureteric obstruction. Kidney Int. 2012.
67. Suzuki Y., Shirato I., Okumura K., Ravetch J.V., Takai T., Tomino Y., Ra C. Distinct contribution of Fc receptors and Angiotensin II-dependent pathways in anti-GBM glomerulonephritis [in process citation]. Kidney Int. 1998, 54:1166-1174.
68. Tang T., Rosenkranz A., Assmann K.J., Goodman M.J., Gutierrez-Ramos J.C., Carroll M.C., Cotran R.S., Mayadas T.N. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J. Exp. Med. 1997, 186:1853-1863.
69. Timoshanko J.R., Kitching R., Semple T.J., Tipping P.G., Holdsworth S.R. A pathogenetic role for mast cells in experimental crescentic glomerulonephritis. J. Am. Soc. Nephrol. 2006, 17:150-159.
70. Tipping P.G., Holdsworth S.R. T cells in crescentic glomerulonephritis. J. Am. Soc. Nephrol. 2006, 17:1253-1263.
71. Trivedi H.S., Pang M.M., Campbell A., Saab P. Slowing the progression of chronic renal failure: economic benefits and patients' perspectives. Am. J. Kidney Dis. 2002, 39:721-729.
72. Veerappan A., Reid A.C., O'Connor N., Mora R., Brazin J.A., Estephan R., Kameue T., Chen J., Felsen D., Seshan S.V., Poppas D.P., Maack T., Silver R.B. Mast cells are required for the development of renal fibrosis in the rodent unilateral ureteral obstruction model. Am. J. Physiol. Renal Physiol. 2012, 302:F192-F204.
73. Wilson C. Renal response to glomerular injury. Brenner and Rector's The Kidney 1996, 1253-1391. WB Saunders, Philadelphia. 5th edition. B.M. Brenner (Ed.).
74. Winearls C.G., Glassock R.J. Dissecting and refining the staging of chronic kidney disease. Kidney Int. 2009, 75:1009-1014.
75. Yamada M., Ueda M., Naruko T., Tanabe S., Han Y.S., Ikura Y., Ogami M., Takai S., Miyazaki M. Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Int. 2001, 59:1374-1381.
76. Zeisberg M., Neilson E.G. Mechanisms of tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 2010, 21:1819-1834.